| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14656566.9.4.587 |
| P8608 | Fatcat ID | release_ch27anb3m5drlco6hscm4nihny |
| P698 | PubMed publication ID | 18312160 |
| P50 | author | Jordi Vila | Q55030523 |
| P2093 | author name string | Jerónimo Pachón | |
| P2860 | cites work | Comparative genomics of multidrug resistance in Acinetobacter baumannii | Q25256737 |
| Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454 | Q28205309 | ||
| Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review | Q28258478 | ||
| Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii | Q30972528 | ||
| Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes | Q33883651 | ||
| Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom | Q33885182 | ||
| Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital | Q33967629 | ||
| Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines | Q33970910 | ||
| Detection of a streptomycin/spectinomycin adenylyltransferase gene (aadA) in Enterococcus faecalis | Q33975922 | ||
| Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii | Q33978798 | ||
| Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii | Q33993176 | ||
| AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters | Q34077047 | ||
| Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii | Q34109543 | ||
| Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea | Q34123619 | ||
| Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia. | Q34128899 | ||
| Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action | Q34510497 | ||
| Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species | Q34555136 | ||
| Rapid development of Acinetobacter baumannii resistance to tigecycline | Q34581377 | ||
| Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001 | Q34941008 | ||
| Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii | Q57179939 | ||
| Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia | Q57212401 | ||
| Colonization or Infection with Multidrug-Resistant Acinetobacter baumannii May Be an Independent Risk Factor for Increased Mortality | Q57232598 | ||
| Prevalencia de los genes tetA y tetB como mecanismo de resistencia a tetraciclina y minociclina en aislamientos clínicos de Acinetobacter baumannii | Q57657482 | ||
| Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain | Q57726411 | ||
| AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus–Acinetobacter baumannii complex | Q58089224 | ||
| High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain | Q58387204 | ||
| Prevalence of ISAba1in epidemiologically unrelatedAcinetobacter baumanniiclinical isolates | Q58387233 | ||
| Outbreak of Infection With Acinetobacter Strain RUH 1139 in an Intensive Care Unit | Q58387310 | ||
| In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia | Q58405456 | ||
| Presence of the Tet M determinant in a clinical isolate of Acinetobacter baumannii | Q35103352 | ||
| AcinetobacterOutbreaks, 1977–2000 | Q35119005 | ||
| The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
| Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology | Q36553871 | ||
| Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia | Q36559388 | ||
| In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria | Q36669161 | ||
| Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. | Q36746061 | ||
| Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization | Q37302581 | ||
| Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward | Q37511391 | ||
| Activities of polymyxin B and cecropin A-,melittin peptide CA(1-8)M(1-18) against a multiresistant strain of Acinetobacter baumannii | Q39653080 | ||
| Molecular characterization of integrons in epidemiologically unrelated clinical isolates of Acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays | Q39657816 | ||
| Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods | Q40282151 | ||
| Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem | Q40290852 | ||
| Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii | Q41038831 | ||
| Transferable plasmid-mediated antibiotic resistance in Acinetobacter | Q41563500 | ||
| Colistin heteroresistance in acinetobacter and its association with previous colistin therapy | Q41912289 | ||
| Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals | Q42167294 | ||
| Characterization of an integron carrying a new class D beta-lactamase (OXA-37) in Acinetobacter baumannii | Q42692542 | ||
| Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitals | Q43120092 | ||
| Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains | Q43552346 | ||
| In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates | Q43635292 | ||
| Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay | Q43798721 | ||
| Group B streptococcal soft tissue infections in non-pregnant adults | Q43817263 | ||
| Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936). | Q43895580 | ||
| Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates | Q43928425 | ||
| Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. | Q43961916 | ||
| Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections. | Q44123853 | ||
| Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam | Q44266822 | ||
| Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. | Q44417867 | ||
| Phenotypic antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter: results of a Multicenter Intensive Care Unit Surveillance Study, 1995-2000. | Q44429042 | ||
| Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial | Q44467386 | ||
| Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study | Q44609136 | ||
| Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis | Q44932019 | ||
| Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings | Q44936182 | ||
| Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000) | Q44944397 | ||
| Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii | Q45050449 | ||
| Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. | Q45152687 | ||
| Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia | Q46335722 | ||
| Successful treatment of Acinetobacter meningitis with meropenem and rifampicin | Q46620852 | ||
| Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii | Q48048984 | ||
| Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones | Q48160362 | ||
| In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii. | Q51091548 | ||
| High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. | Q53563596 | ||
| Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events. | Q53851336 | ||
| Comparison of three standardized disc susceptibility testing methods for colistin. | Q54457812 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Acinetobacter baumannii | Q3241189 |
| P304 | page(s) | 587-599 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Expert Opinion on Pharmacotherapy | Q5421212 |
| P1476 | title | Therapeutic options for Acinetobacter baumannii infections | |
| P478 | volume | 9 |
| Q36417501 | Acinetobacter baumannii Septicemia in a Recipient of an Allogeneic Hematopoietic Stem Cell Transplantation |
| Q38008459 | Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models |
| Q82280648 | Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine |
| Q39649887 | Activity of Gallium Meso- and Protoporphyrin IX against Biofilms of Multidrug-Resistant Acinetobacter baumannii Isolates |
| Q58589290 | Antimicrobial Survey of Local Herbal Drugs against Isolated from Patients Admitted to a Level-I Trauma Center |
| Q90235595 | Co-production of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt |
| Q40931929 | Co-production of ESBL and AmpC β-Lactamases in Clinical Isolates of A. baumannii and A. lwoffii in a Tertiary Care Hospital From Northern India |
| Q31071263 | Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strain |
| Q35222421 | Comparison of colistin monotherapy and non-colistin combinations in the treatment of multi-drug resistant Acinetobacter spp. bloodstream infections: a multicenter retrospective analysis |
| Q42228164 | Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections. |
| Q42545818 | CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii |
| Q30152905 | Crystal Structure of Hcp from Acinetobacter baumannii: A Component of the Type VI Secretion System |
| Q57179932 | Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumannii |
| Q43150667 | Efficacy of tigecycline vs. imipenem in the treatment of experimental Acinetobacter baumannii murine pneumonia. |
| Q42643475 | Extended spectrum and metalo beta-lactamase producing airborne Pseudomonas aeruginosa and Acinetobacter baumanii in restricted settings of a referral hospital: a neglected condition |
| Q34653632 | Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection |
| Q37392820 | In vitro activity and in vivo efficacy of clavulanic acid against Acinetobacter baumannii. |
| Q43234796 | In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii |
| Q83310118 | In-silico modeling of a novel OXA-51 from β-lactam-resistant Acinetobacter baumannii and its interaction with various antibiotics |
| Q46151080 | Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice |
| Q50134154 | Molecular epidemiology and mechanism of sulbactam resistance in Acinetobacter baumannii isolates with diverse genetic background in China |
| Q37785545 | Multidrug-resistant Gram-negative infections: the use of colistin. |
| Q92647773 | Pandrug-resistant Acinetobacter Baumannii Infection Identified in a Non-intensive Care Unit Patient: A Case Study |
| Q43451889 | Pharmacophore generation of 2-substituted benzothiazoles as AdeABC efflux pump inhibitors in A. baumannii. |
| Q64118346 | Phenotypic and Genotypic Characterization of spp. Panel Strains: A Cornerstone to Facilitate Antimicrobial Development |
| Q33901939 | Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. |
| Q53291076 | Quantitative Proteomic Analysis of Cell Wall and Plasma Membrane Fractions from Multidrug-Resistant Acinetobacter baumannii |
| Q42273592 | Rapid detection of antibiotic resistance in Acinetobacter baumannii using quantitative real-time PCR. |
| Q39584788 | Rifampin protects human lung epithelial cells against cytotoxicity induced by clinical multi and pandrug-resistant Acinetobacter baumannii. |
| Q40045652 | The outer membrane porin OmpW of Acinetobacter baumannii is involved in iron uptake and colistin binding |
| Q38049332 | Therapeutic options for Acinetobacter baumannii infections: an update |
| Q57543752 | Tigecycline in carbapenem-resistant Acinetobacter baumannii bacteraemia: Susceptibility and clinical outcome |
| Q34484474 | Vaccination with Outer Membrane Complexes Elicits Rapid Protective Immunity to Multidrug-Resistant Acinetobacter baumannii |
| Q40207057 | Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection |
| Q37393081 | Xuebijing Protects Rats from Sepsis Challenged with Acinetobacter baumannii by Promoting Annexin A1 Expression and Inhibiting Proinflammatory Cytokines Secretion |
Search more.